Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
BACKGROUND: The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. METHODS: We evaluated tocilizumab ...